ENDOCRINE PRACTICE Vol 25 No. 11 November 2019 1191 Copyright © 2019 AACE AACE 2019 Guidelines AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF GROWTH HORMONE DEFICIENCY IN ADULTS AND PATIENTS TRANSITIONING FROM PEDIATRIC TO ADULT CARE 2019 AACE GROWTH HORMONE TASK FORCE Kevin C. J. Yuen, MD, FRCP, FACE 1 ; Beverly M. K. Biller, MD, FACP 2 ; Sally Radovick, MD 3 ; John D. Carmichael, MD 4 ; Sina Jasim, MD, MPH 5 ; Kevin M. Pantalone, DO, FACE, ECNU 6 ; Andrew R. Hoffman, MD 7 Submitted for publication September 6, 2019 Accepted for publication October 11, 2019 From the 1 Barrow Pituitary Center, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, University of Arizona College of Medicine and Creighton School of Medicine, Phoenix, Arizona, the 2 Neuroendocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, the 3 Division of Endocrinology, Department of Pediatrics, Rutgers Robert Wood Johnson School of Medicine, New Brunswick, New Jersey, the 4 Division of Endocrinology, Department of Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, 5 Division of Endocrinology, Metabolism and Lipid Research, Washington University, School of Medicine, St. Louis, Missouri, the 6 Department of Endocrinology, Diabetes, and Metabolism, Cleveland Clinic, Cleveland, Ohio, and the 7 Department of Medicine, VA Palo Alto Health Care System and Stanford University School of Medicine, Palo Alto, California. Address correspondence to Dr. Kevin C.J. Yuen, Barrow Pituitary Center, Departments of Neuroendocrinology and Neurosurgery, Barrow Neurological Institute, 124 West Thomas Road, Suite 300, Phoenix, AZ 85013. E-mail: [email protected]. Published as a Rapid Electronic Article in Press at http://www.endocrine practice.org. DOI: 10.4158/GL-2019-0405 To purchase reprints of this article, please visit: www.aace.com/reprints. Copyright © 2019 AACE. This document represents the official position of the American Association of Clinical Endocrinologists and American College of Endocrinology. Where there were no randomized controlled trials or specific U.S. FDA labeling for issues in clinical practice, the participating clinical experts utilized their judgment and experience. Every effort was made to achieve consensus among the committee members. Position statements are meant to provide guidance, but they are not to be considered prescriptive for any individual patient and cannot replace the judgment of a clinician. This is an Open Access article under the CC-BY-NC license. -ND
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Related Documents
